Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Lawsuit Filed Against Allergan for Defectively Packaged Taytulla™ Birth Control That Allegedly Caused Unintended Pregnancy
  • USA - English


News provided by

Chaffin Luhana LLP

Jun 13, 2018, 08:00 ET

Share this article

Share toX

Share this article

Share toX

NEW YORK (PRWEB) June 13, 2018 -- On behalf of a Miami, FL woman who allegedly experienced an unintended pregnancy due to a manufacturing error of Taytulla™ birth control, Chaffin Luhana LLP, a national plaintiffs-only law firm in New York City, and Baron & Herskowitz of Miami, Florida have filed the first product liability lawsuit (Case: MRS-L-001122-18) against Taytulla’s™ manufacturer, Allergan USA, Inc. and related entities (“Allergan”), in New Jersey state court in an effort to recover damages for the plaintiff.

The complaint alleges that the plaintiff received samples of Taytulla™ from her doctor in or around January 2018 and that she used the birth control as directed. In March 2018, she learned that she was pregnant even though she was actively taking the Taytulla™ birth control as directed. Approximately four days later, her pregnancy failed, and she suffered a miscarriage.

The plaintiff alleges that the capsules in the sample pack of Taytulla™ that she received were part of a recent recall triggered by a manufacturing error at an Allergan facility which caused the birth control capsules to be packaged in reverse order. The capsules were rotated 180 degrees within the blister pack, placing the inactive placebo pills at the beginning of the month, instead of in their proper location at the end of the month. The plaintiff learned of the manufacturing defect only after she became pregnant while taking Taytulla™.

Taytulla™ was first approved by the U.S. Food and Drug Administration (FDA) on April 19, 2013 and has been marketed as almost 100% effective at preventing pregnancies. Taytulla™ is also known as the first and only softgel oral contraceptive for women.

On March 29, 2018, Allergan recalled all Taytulla™ 1 mg/20mcg, 6x28 physician sample packs bearing Lot# 5620706 with an expiration date of May 2019, due to the manufacturing error. The recall covers a total of approximately 170,000 sample packs. The plaintiff alleges that she was using one of the sample packs from the defective lot. According to Allergan, the manufacturing defect was originally identified through a physician report, which noted that four placebo pills were placed at the beginning of a sample pack, instead of at the end of the treatment cycle.

“Our firm has a long history of being on the forefront of defective birth control litigation to get just compensation for women and their families who have suffered injuries from defective birth control drugs and medical devices,” said Chaffin Luhana founding partner Eric Chaffin.

Baron and Herskowitz for many years has been representing those injured because of negligence, manufacturing defects, and defective products with success in settlement and at trial. “Our firm is founded on the principles of helping those who have been injured by others and preventing future harm through responsibility and proper oversight,” said partner Jon Herskowitz. “We look forward to combining our class action and trial experience with Chaffin Luhana who has had incredible success in helping individuals in these types of cases.”

The plaintiff brings counts of consequential damages include physical suffering, mental anguish, and other actual damages permitted by law.

Chaffin Luhana, along with their co-counsel of Baron & Herskowitz, are actively investigating additional cases for women who may have received and used the defective Taytulla birth control packs.

About Chaffin Luhana:
Chaffin Luhana LLP has a successful history of protecting the rights of those who have suffered catastrophic injuries as the result of defective products, dangerous pharmaceutical drugs, and defective medical devices, including women who have been injured from defective birth control products. The firm has handled many high-profile cases in federal and state courts across the country, provided new online resource centers for clients and the public, and has successfully recovered millions of dollars for women who have suffered injuries from various defective birth control pills and devices.

To date, the attorneys of Chaffin Luhana LLP have been involved in recovering over $1 billion for their clients during their careers, and the firm itself has recovered hundreds of millions of dollars for individually injured plaintiffs. Though unable to guarantee results, the firm has a distinguished track record of success and is highly committed to each case.

About Baron & Herskowitz:
Baron & Herskowitz for many years has represented clients in tort litigation and class action litigation who have suffered significant injuries as the result of negligence, defective products, devices, improper fees, and consumer products.

If you or a loved one has suffered an injury that may be related to a dangerous or defective product, contact Chaffin Luhana LLP or Baron & Herskowitz for a free and confidential case review at 1-888-480-1123, or visit Chaffin Luhana’s website at https://www.chaffinluhana.com.

Attorney Advertising. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Eric Chaffin, Chaffin Luhana LLP, https://www.chaffinluhana.com/, +1 (888) 480-1123, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.